Monoclonal antibody prevents HIV infection in monkeys, study finds

Leronlimab to be studied as potential HIV PrEP drug in an early human clinical trial

By Franny White June 07, 2021 Portland, Oregon

Weill Cornell Medicine

Jonah Sacha, Ph.D., at OHSU's Oregon National Primate Research Center and Vaccine & Gene Therapy Institute. (OHSU/Kristyna Wentz-Graff)